Clinical Trials

300 enrolled

Lung Neoplasms

NCT07481786 2026-04-06

Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases

Phase 3 Active not recruiting

220 enrolled

CNSThoracic

Adenocarcinoma of Lung, Brain Neoplasms

NCT03390686 2025-05-31

A Trial to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity of HD204 to Avastin® in Advanced Non-squamous Non-small Cell Lung Cancer Patients

650 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03676192 2025-03-17

To Compare Efficacy and Safety of CT-P16 and European Union-Approved Avastin as First-Line Treatment for Metastatic or Recurrent Non-Squamous Non-Small Cell Lung Cancer

689 enrolled 18 charts

Adenocarcinoma of Lung

NCT00324805 2025-03-03

Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery

1,501 enrolled 16 charts

Carcinoma, Non-Small-Cell Lung

NCT02754882 2024-12-16

A Study Comparing SB8 and Avastin® in Patients With Advanced Non-squamous Non-small Cell Lung Cancer

763 enrolled 19 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04325698 2024-10-01

A BRIDGING STUDY OF PF-06439535 (CN) PLUS PACLITAXEL-CARBOPLATIN VERSUS BEVACIZUMAB PLUS PACLITAXEL-CARBOPLATIN IN NSCLC

Phase 3 Terminated

8 enrolled 6 charts

Advanced Non-squamous NSCLC

NCT05654454 2024-08-16

A Safety and Efficacy Study of Bevacizumab, Paclitaxel, Carboplatin Compared to Avastin® in Non-Small Cell Lung Cancer

620 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05055908 2024-08-02

BECOME

12,000 enrolled

Lung Neoplasms

NCT04194203 2024-07-19

A Study of Bevacizumab, Carboplatin, and Paclitaxel or Pemetrexed With or Without Atezolizumab in Chemotherapy-Naïve Patients With Stage IV Non-Squamous Non-Small Cell Lung Cancer (IMpower151)

305 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03117049 2024-05-06

Study of ONO-4538 in Non-Squamous Non-Small Cell Lung Cancer (TASUKI-52)

550 enrolled 21 charts

Carcinoma, Non-Small-Cell Lung

NCT01763645 2024-01-11

A Safety and Efficacy Study of BCD-021 With Paclitaxel and Carboplatin Compared to Avastin With Paclitaxel and Carboplatin in Non-Small Cell Lung Cancer

353 enrolled 14 charts

Carcinoma, Non-Small-Cell Lung

NCT05318443 2023-12-27

A Study Exploring Efficacy of SIBP04 in Subjects With Non-squamous Non-small Cell Lung Cancer

512 enrolled

Non-squamous Non-small-cell Lung Cancer

NCT01107626 2023-07-07

Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer

1,516 enrolled 12 charts

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04466917 2023-07-03

A Study of ABP 215 Versus Bevacizumab in Chinese Subjects With Advanced Non-Squamous Non-Small Cell Lung Cancer

Phase 3 Withdrawn

Carcinoma, Non-Small-Cell Lung

NCT00946712 2023-05-23

S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer

Phase 3 Terminated

1,333 enrolled 22 charts

Adenocarcinoma of Lung

NCT03991403 2023-04-03

Study of Atezolizumab Combination Carboplatin + Paclitaxel + Bevacizumab in EGRF Mutation or ALK Translocation NSCLC

228 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05104281 2023-03-29

Osimertinib Combined With Bevacizumab in Patients With Brain Metastasis Epidermal Growth Factor Receptor (EGFR) Mutation Positive Metastatic Non-Small Cell Lung Cancer

60 enrolled

Bronchial Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT02633189 2023-03-24

BEVERLY

200 enrolled

Non-squamous Non-small Cell Lung Cancer

NCT01763671 2023-03-14

Ultimate

166 enrolled

Lung Neoplasms

NCT03196986 2023-01-31

mil60 Versus Bevacizumab in Patients With Treatment-naïve Non-squamous Non-small Cell Lung Cancer

517 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05648071 2022-12-13

SPBPDC

60 enrolled

Advanced Non-squamous Non-Small-Cell Lung Cancer

NCT04633564 2022-03-16

MYL-1402O Compared With Avastin®, in Patients With Stage IV nsNSCLC

671 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT02810457 2022-03-10

AVANA

731 enrolled 19 charts

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT05169801 2021-12-27

To Compare the Efficacy and Safety of BP102 vs. Avastin® in Combination With Paclitaxel/Carboplatin in First-line Treatment of Advanced or Relapsed NSCLC

520 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02743923 2021-12-21

Cisplatin-Pemetrexed Compared With Carboplatin-Paclitaxel-Bevacizumab in KRAS Mutated Non-small Cell Lung Cancer

203 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05132413 2021-11-24

A Study of SHR-1701 Plus Bevacizumab and Chemotherapy in Non-Small-Cell-Lung-Cancer

561 enrolled

Advanced or Metastatic Non-squamous Non-small-cell Lung Cancer

NCT00948675 2021-10-29

Study of Participants With Advanced Non-Small Cell Lung Cancer

361 enrolled 13 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02366143 2021-09-23

IMpower150

1,202 enrolled 35 charts

Carcinoma, Non-Small-Cell Lung

NCT03296163 2021-04-26

STELLA

627 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT00130728 2021-01-14

A Study to Evaluate the Efficacy of Bevacizumab in Combination With Tarceva for Advanced Non-Small Cell Lung Cancer

636 enrolled 14 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02272413 2020-01-13

Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung Cancer

671 enrolled 16 charts

Carcinoma, Non-Small-Cell Lung

NCT02162537 2019-02-01

METAL2

Phase 3 Terminated

95 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03792074 2019-01-03

To Evaluate the Efficacy and Safety of SCT510 in the Treatment of Non-small Cell Lung Cancer

560 enrolled

Non-squamous Cell Non-small Cell Lung Cancer

NCT03169335 2018-08-24

Efficacy and Safety of QL1101 and Avastin® Respectively Combined With Paclitaxel and Carboplatin in the First-line Treatment of Non-squamous Non-small Cell Lung Cancer

535 enrolled

Non-squamous Non-small Cell Lung Cancer

NCT03533127 2018-07-10

A Study of LY01008 and Bevacizumab Combined With Paclitaxel and Carboplatin for Treatment of Naïve Subjects With Metastatic or Recurrent Nonsquamous Non-small Cell Lung Cancer

648 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01364012 2018-02-05

A Study of Bevacizumab Versus Placebo in Combination With Carboplatin/Paclitaxel in Participants With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Previous Chemotherapy

276 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01966003 2017-10-19

Efficacy and Safety Study of ABP 215 Compared With Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer

642 enrolled 17 charts

Non-small Cell Lung Cancer Metastatic

NCT01351415 2017-09-18

A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)

485 enrolled 15 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT00806923 2016-11-02

A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

1,044 enrolled

Non-Squamous Non-Small Cell Lung Cancer

NCT00257608 2016-04-18

A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)

1,145 enrolled 13 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00976456 2016-03-10

65plus

271 enrolled 8 charts

Lung Neoplasms

NCT00961415 2016-02-22

AVAPERL1 Study: A Study of Avastin (Bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small Cell Lung Cancer

376 enrolled 14 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT00762034 2015-12-21

A Study of Pemetrexed, Carboplatin and Bevacizumab in Participants With Nonsquamous Non-Small Cell Lung Cancer

939 enrolled 39 charts

Carcinoma, Non-Small-Cell Lung

NCT01661790 2015-03-25

Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer

72 enrolled 5 charts